ELIQUENT Life Sciences
Sarah Haverin currently serves as the Senior Vice President of Business Development at ELIQUENT Life Sciences, a position attained in July 2022 following the company's acquisition by private equity, where responsibilities include strategic leadership, sales forecasting, and team development. Previously, Sarah was the Vice President of Business Development at Oriel STAT A MATRIX, driving growth in the medical device and IVD sector from January 2015 to July 2022. Early career roles included Business Development Manager at Emergo Group and Senior Research Associate at Monash University, where research focused on critical therapeutic areas. Sarah holds an MBA in International Business from Texas State University and a Bachelor's degree in Genetics, Microbiology, and Molecular Biology from Monash University.
This person is not in any teams
This person is not in any offices
ELIQUENT Life Sciences
We are expert consultants delivering the answers and solutions that life sciences innovators need to gain and maintain market authorization for their products. Our unprecedented assembly of regulatory leaders, industry experts, and technical specialists collaborate seamlessly to unlock excellence throughout the product lifecycle. We are the convergence of regulatory expertise and technical capabilities across the therapeutic landscape. From thought to finish, concept to commerce, and strategy to execution— ELIQUENT Life Sciences is the singular regulatory resource that clients around the world trust. ELIQUENT Life Sciences is comprised of five global consultancies working as a collective, coordinated regulatory team. The ELIQUENT team includes: VALIDANT: A full-service life science consulting firm providing strategy, execution, and ongoing support for a range of regulatory, compliance, and quality needs. GREENLEAF HEALTH: A leading FDA regulatory consulting firm that provides strategic and technical guidance to pharmaceutical, biotechnology, and medical device companies. DATAREVIVE: A regulatory consultancy firm with expertise to deliver CMC, preclinical, clinical, and GxP expertise to innovators seeking product approvals in major global markets. ORIEL STAT-A-MATRIX: A global leader in training and consulting for business process improvement, regulatory compliance, and quality management systems. IDEC: A regionally specialized regulatory guidance and end-to-end product support for pharmaceutical innovators seeking approval in the Japanese market. Together, ELIQUENT redefines regulatory consulting with a full-service approach and comprehensive solutions that bridge the spectrum of regulatory challenges. Learn more at ELIQUENT.com